The reduction of microalbuminuria in Japanese Hypertensive subjects with type 2 diabetes mellitus treated with valsartan or amlodipine: study design for the Shiga Microalbuminuria Reduction Trial (SMART)
Latest Information Update: 03 Nov 2021
Price :
$35 *
At a glance
- Drugs Amlodipine (Primary) ; Valsartan (Primary)
- Indications Diabetic nephropathies; Hypertension; Proteinuria
- Focus Therapeutic Use
- Acronyms SMART
- 05 Jun 2007 Results have been reported.
- 25 Oct 2006 Status change
- 08 Sep 2006 New trial record.